tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
AnaptysBio announces intent to separate into two publicly traded companies
PremiumThe FlyAnaptysBio announces intent to separate into two publicly traded companies
10d ago
AnaptysBio trading halted, news pending
Premium
The Fly
AnaptysBio trading halted, news pending
10d ago
AnaptysBio jumps after Englander’s Millennium takes stake
Premium
The Fly
AnaptysBio jumps after Englander’s Millennium takes stake
15d ago
AnaptysBio’s Promising Pipeline and Financial Stability Justify Buy Rating
PremiumRatingsAnaptysBio’s Promising Pipeline and Financial Stability Justify Buy Rating
2M ago
AnaptysBio price target raised to $45 from $40 at Wedbush
Premium
The Fly
AnaptysBio price target raised to $45 from $40 at Wedbush
2M ago
Promising Clinical Trial Results and Strategic Growth Potential Drive Buy Rating for AnaptysBio
Premium
Ratings
Promising Clinical Trial Results and Strategic Growth Potential Drive Buy Rating for AnaptysBio
2M ago
AnaptysBio Holds 2025 Annual Stockholders Meeting
PremiumCompany AnnouncementsAnaptysBio Holds 2025 Annual Stockholders Meeting
4M ago
AnaptysBio shares are undervalued, says JPMorgan
Premium
The Fly
AnaptysBio shares are undervalued, says JPMorgan
4M ago
AnaptysBio participates in a conference call with JPMorgan
Premium
The Fly
AnaptysBio participates in a conference call with JPMorgan
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100